Stay updated on DECIDE Clinical Trial: Dapagliflozin vs. Standard Care
Sign up to get notified when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.

Latest updates to the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPage revision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedStatus updated to Completed with new dates; the previous 'Active, not recruiting' designation was removed.SummaryDifference0.4%

- Check42 days agoChange DetectedAdded Type 2 diabetes as a study topic and included a related topic link to MedlinePlus Genetics.SummaryDifference0.1%

- Check49 days agoChange DetectedThe update adds a new revision label (v3.4.2) and removes non-study topics and an older revision note, with no impact on the study details or user interactions on the page.SummaryDifference0.3%

- Check56 days agoChange DetectedAdded a site-wide notice regarding a lapse in government funding and the NIH operating status, and updated the revision from v3.4.0 to v3.4.1. These changes are administrative and do not affect study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to DECIDE Clinical Trial: Dapagliflozin vs. Standard Care
Enter your email address, and we'll notify you when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.